| Synonyms: | |
| Status: | Phase 2 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| UNII: | WDT5V5OB9F |
| InChI Key | URCVCIZFVQDVPM-UHFFFAOYSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C18H17N3O4S |
| Molecular Weight | 371.42 |
| AlogP | 3.34 |
| Hydrogen Bond Acceptor | 6.0 |
| Hydrogen Bond Donor | 3.0 |
| Number of Rotational Bond | 6.0 |
| Polar Surface Area | 100.55 |
| Molecular species | NEUTRAL |
| Aromatic Rings | 3.0 |
| Heavy Atoms | 26.0 |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Structural protein
|
- | 2200-3200 | - | 1510 | 40-96 |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Neuroblastoma | 2 | D009447 | ClinicalTrials |
| Carcinoma, Renal Cell | 2 | D002292 | ClinicalTrials |
| Carcinoma, Non-Small-Cell Lung | 2 | D002289 | ClinicalTrials |
| Colorectal Neoplasms | 2 | D015179 | ClinicalTrials |
| Breast Neoplasms | 2 | D001943 | ClinicalTrials |
| Hematologic Neoplasms | 1 | D019337 | ClinicalTrials |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | D054198 | ClinicalTrials |
| Prostatic Neoplasms, Castration-Resistant | 1 | D064129 | ClinicalTrials |
| Resources | Reference |
|---|---|
| CAS NUMBER | 141430-65-1 |
| ChEBI | 95043 |
| ChEMBL | CHEMBL20684 |
| DrugBank | DB12254 |
| FDA SRS | WDT5V5OB9F |
| PDB | E70 |
| PubChem | 3035714 |
| SureChEMBL | SCHEMBL111645 |
| ZINC | ZINC000000598089 |